AR039404A1 - Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion - Google Patents
Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacionInfo
- Publication number
- AR039404A1 AR039404A1 ARP030101265A ARP030101265A AR039404A1 AR 039404 A1 AR039404 A1 AR 039404A1 AR P030101265 A ARP030101265 A AR P030101265A AR P030101265 A ARP030101265 A AR P030101265A AR 039404 A1 AR039404 A1 AR 039404A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- pyridyl
- phenyl
- methyl
- single bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Suspension/Interruption
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composiciones medicamentosas a base de un anticolinérgico 1 y compuestos heterocíclicos 2, procedimientos para su preparación, así como a su utilización en la terapia de enfermedades de las vías respiratorias. Reivindicación 1: Medicamento caracterizado por un contenido en una o varias, preferentemente una sal de la fórmula (1) en la cual: X- significa un anión monocargado negativamente, preferentemente un anión seleccionado del grupo constituido por cloruro, bromuro, yoduro, sulfato, fosfato, metanosulfonato, nitrato, maleato, acetato, citrato, fumarato, tartrato, oxalato, succinato, benzoato, y p-toluenosulfonato, en combinación con uno o varios, preferentemente un compuesto de la fórmula general (2) en la cual pueden significar: R1 hidrógeno, metilo, etilo, n-butilo, i-butilo, fenilo, 2-etilfenilo, 2-i-propilfenilo, bencilo, 4-piridilo, 2-piridilo, -CO-fenilo, CN ó, junto con R2, un puente butileno ó pentileno; R2 hidrógeno, metilo, etilo o, junto con R1, un puente butileno o pentileno o, junto con R13, un enlace sencillo o un puente butileno; R3 hidrógeno; R4 metoxi; R5 ciclohexilo, fenilo, 3-metoxicarbonilfenilo, 4-metoxicarbonilfenilo, 3-carboxifenilo, 4-carboxifenilo, CN, -COOH, -COOMe, -COOEt, 3,5-dicloro-piridina-4-il, 4-piridilo ó 4-piridil-N-óxido; A es oxígeno ó -CH2-; B es oxígeno o uno de los grupos -C(R12)(R13)- ó -CH(R15)-CH(R17)-; D es un grupo seleccionado de -CH2-CH2-, -CH(Ph)-CH2-, -CONH-, -CO-CH2-, -CH=CH-, -C(Ph)=CH-, -C(R18)(R19)-X-, -C(R19a)=Y-, -CsC- ó fenileno; R12 es hidrógeno, metilo, etilo, i-propilo, fenilo ó -CH2-CORx; R13 es hidrógeno ó, junto con R2, un enlace sencillo o un puente butileno; R15 es hidrógeno o, junto R17, un enlace sencillo; R17 es hidrógeno o, junto con R15, un enlace sencillo; R18 es hidrógeno o metilo; R19 es hidrógeno, metoxi, fenilo o CN; R19a es hidrógeno, metilo ó fenilo; Rx es hidroxi, etoxi, benciloxi, 2-feniletiloxi, 4-metil-piperazin-1-il, 4-fenilpirerazin-1-il, N-tetrahidro-isoquinolinilo, -NH-fenilo, -NH-bencilo, -NH-CH2-(4-metoxifenilo), -NH-CH2-(4-fluorofenilo), -NH-CH2-(4-clorofenilo), -NH-CH2-(2-clorofenilo), -NH-(3-piridilo), -NH-CH2-(2-piridilo), -NH-CH2-(3-piridilo), -NH-CH2-(4-piridilo), -NH-(3,5-dicloropiridin-4-il) ó -NH-(2-pirimidinilo); X es -CH2-, -S-, ó -NH-; Y es CH, CCN, CCOOEt ó CHCONH, eventualmente en forma de los isómeros ópticos individuales, mezclas de los mismos ó racematos, así como eventualmente en forma de sus sales por adición de ácidos, farmacológicamente tolerables, eventualmente en forma de sus solvatos o hidratos, así como eventualmente conjuntamente con un coadyuvante farmacéuticamente tolerable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10216427A DE10216427A1 (de) | 2002-04-12 | 2002-04-12 | Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum |
Publications (1)
Publication Number | Publication Date |
---|---|
AR039404A1 true AR039404A1 (es) | 2005-02-16 |
Family
ID=28458800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101265A Suspension/Interruption AR039404A1 (es) | 2002-04-12 | 2003-04-11 | Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion |
Country Status (8)
Country | Link |
---|---|
US (1) | US20040002502A1 (es) |
AR (1) | AR039404A1 (es) |
AU (1) | AU2003221562A1 (es) |
DE (1) | DE10216427A1 (es) |
PE (1) | PE20040084A1 (es) |
TW (1) | TW200406209A (es) |
UY (1) | UY27759A1 (es) |
WO (1) | WO2003087049A2 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
US7417051B2 (en) * | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
US20040058950A1 (en) * | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
US20040048886A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists |
US20040048887A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors |
US20040044020A1 (en) * | 2002-07-09 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors |
US20040166065A1 (en) | 2002-08-14 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation comprising an anticholinergic |
US7244742B2 (en) * | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
US8603296B2 (en) | 2002-10-07 | 2013-12-10 | Georgia-Pacific Consumer Products Lp | Method of making a fabric-creped absorbent cellulosic sheet with improved dispensing characteristics |
US7494563B2 (en) | 2002-10-07 | 2009-02-24 | Georgia-Pacific Consumer Products Lp | Fabric creped absorbent sheet with variable local basis weight |
US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US7332175B2 (en) * | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
DE10345065A1 (de) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
US20050272726A1 (en) * | 2004-04-22 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Novel medicaments for the treatment of respiratory diseases |
US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
JP5270343B2 (ja) * | 2005-08-15 | 2013-08-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ベータミメティックスの製造方法 |
US7599861B2 (en) | 2006-03-02 | 2009-10-06 | Convergys Customer Management Group, Inc. | System and method for closed loop decisionmaking in an automated care system |
US8379830B1 (en) | 2006-05-22 | 2013-02-19 | Convergys Customer Management Delaware Llc | System and method for automated customer service with contingent live interaction |
US7809663B1 (en) | 2006-05-22 | 2010-10-05 | Convergys Cmg Utah, Inc. | System and method for supporting the utilization of machine language |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2540633A1 (de) * | 1975-09-12 | 1977-04-28 | Boehringer Sohn Ingelheim | Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung |
US5770738A (en) * | 1992-03-05 | 1998-06-23 | Boehringer Ingelheim Kg | Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
JP4172817B2 (ja) * | 1995-05-19 | 2008-10-29 | 協和醗酵工業株式会社 | 含酸素複素環化合物 |
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
US6706726B2 (en) * | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
US20020193393A1 (en) * | 2001-03-07 | 2002-12-19 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
DE10200943A1 (de) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
US7417051B2 (en) * | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
US20040048887A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors |
US20040048886A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists |
US20040044020A1 (en) * | 2002-07-09 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors |
US20040058950A1 (en) * | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
US20040166065A1 (en) * | 2002-08-14 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation comprising an anticholinergic |
US7244742B2 (en) * | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
US7332175B2 (en) * | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
TWI259994B (en) * | 2003-07-21 | 2006-08-11 | Ali Corp | Adaptive multiple levels step-sized method for time scaling |
DE10345065A1 (de) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
US20050154006A1 (en) * | 2004-01-09 | 2005-07-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
US20050186175A1 (en) * | 2004-02-20 | 2005-08-25 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins |
-
2002
- 2002-04-12 DE DE10216427A patent/DE10216427A1/de not_active Withdrawn
-
2003
- 2003-04-08 US US10/409,402 patent/US20040002502A1/en not_active Abandoned
- 2003-04-09 AU AU2003221562A patent/AU2003221562A1/en not_active Abandoned
- 2003-04-09 WO PCT/EP2003/003670 patent/WO2003087049A2/de not_active Application Discontinuation
- 2003-04-10 PE PE2003000366A patent/PE20040084A1/es not_active Application Discontinuation
- 2003-04-10 UY UY27759A patent/UY27759A1/es not_active Application Discontinuation
- 2003-04-10 TW TW092108228A patent/TW200406209A/zh unknown
- 2003-04-11 AR ARP030101265A patent/AR039404A1/es not_active Suspension/Interruption
Also Published As
Publication number | Publication date |
---|---|
TW200406209A (en) | 2004-05-01 |
AU2003221562A1 (en) | 2003-10-27 |
US20040002502A1 (en) | 2004-01-01 |
PE20040084A1 (es) | 2004-04-01 |
WO2003087049A3 (de) | 2004-02-05 |
UY27759A1 (es) | 2003-11-28 |
DE10216427A1 (de) | 2003-10-23 |
AU2003221562A8 (en) | 2003-10-27 |
WO2003087049A2 (de) | 2003-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR039404A1 (es) | Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion | |
ES2655527T3 (es) | Derivados novedosos de amino pirimidina | |
ES2625944T3 (es) | Inhibidores de tirosina cinasa de Bruton | |
BR112020014160A2 (pt) | Compostos de benzamida | |
CA2749730C (en) | Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction | |
BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
RU2006144123A (ru) | Новые энантиомерночистые в-агонисты, способ их получения и их применение в качестве лекарственных средств | |
NO20065638L (no) | Formuleringer med kontrollert frigivelse inneholdende vardenafil | |
AR055669A1 (es) | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. | |
IL166814A0 (en) | Aerosol formulation for inhalation containing an anticholinergic agent | |
RU2000102359A (ru) | Фармацевтическая композиция, обладающая улучшенным противораковым действием и/или сниженными побочными эффектами, содержащая противораковый агент и производное гидроксамовой кислоты | |
RU2006119914A (ru) | Применение ингибиторов глюкозидазы для терапии муковисцидоза | |
CN109996546A (zh) | P2x3和/或p2x2/3化合物及方法 | |
NO20044545L (no) | Piperidin-eller 8-aza-bicyklo[3.2.1.]okt-3-yl derivater som er nyttige som modulatorer for kemokireseptoraktivitet (spesielt CCR5) | |
WO2004000355A1 (en) | Combination treatment for depression and anxiety by nk1 and nk3 antagonists | |
ES2220975T3 (es) | Tratamiento de trastornos producidos por factores de crecimiento de citoquina. | |
AR038824A1 (es) | Composiciones de medicamentos que, junto a agentes colinergicos, contienen compuestos heterociclicos | |
ES2358931T3 (es) | Uso de un inhibidor de quinasa p38 para el tratamiento de trastornos psiquiatricos. | |
AU700520B2 (en) | NK-1 receptor antagonists for the treatment of cancer | |
MEP54208A (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
CN107847493A (zh) | 镇咳药组合物和方法 | |
ES2532000T3 (es) | Composición farmacéutica para el tratamiento de la dependencia del alcohol | |
MY138940A (en) | Inhalable formulation of a solution containing a tiotropium salt. | |
MY133438A (en) | Morpholinobenzamide salts | |
AR039634A1 (es) | Medicamento que contiene betamimeticos y un anticolinergico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |